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In this study, we used melb-a melanoblasts as a model
to study mechanisms involved in stimulating melano-
cyte function in vitiliginous skin following exposure to
8-methoxypsoralen (8MOP). Melanin content and tyro-
sinase activity increased 3- and 7-fold, respectively, in
melanoblasts treated with 8MOP for 6 d compared with
untreated controls. The intracellular signal pathways in-
volved in 8MOP-induced e¡ects on melanoblasts were
investigated, particularly the roles of protein kinase A
and protein kinase C. Forskolin, a protein kinase A ac-
tivator, mimicked and enhanced the 8MOP stimulation
of melanoblast pigmentation whereas a protein kinase
C activator, 1-oleoyl-2-acetylglycerol, had no e¡ect, in-
dicating that the protein kinase A pathway is involved
rather than the protein kinase C pathway. Those obser-
vations were con¢rmed using inhibitors of the protein
kinase A or protein kinase C pathways. Western blot
and semiquantitative reverse transcriptase polymerase
chain reaction were performed to assess the protein
and mRNA expression levels of microphthalmia-asso-
ciated transcription factor and tyrosinase in melano-
blasts treated with 8MOP for 3 h, 6 h, 1 d, 3 d, or 6 d.
Incubation with 8MOP stimulated microphthalmia-as-
sociated transcription factor protein and mRNA levels
within 3 h, but, in contrast, tyrosinase mRNA and pro-
tein levels did not increase following 8MOP treatment
until 1 d after treatment. The proteasome inhibitor lac-
tacystin blocked the proteasome-mediated proteolysis
of tyrosinase, and its e¡ect on proteasomal function
was enhanced by 8MOP. Taken together, these results
show that 8MOP functions by initially stimulating le-
vels of microphthalmia-associated transcription factor
expression via activation of the protein kinase A path-
way, which thereby stimulates tyrosinase expression
and function and eventually leads to dramatic increases
in melanin production by melanoblasts. Key words:
melanoblast/pigmentation/psoralens/Mitf. J Invest Dermatol
119:1341 ^1349, 2002
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itiligo is a condition characterized by the loss of pig-
ment cells in the epidermis. It can involve any part
of the body where melanocytes reside and it causes
both functional and physiologic abnormalities in
the a¡ected skin. Although vitiligo may be rela-
tively invisible on fair-skinned persons, for those with a dark
complexion the cosmetic dis¢gurement arising from vitiligo can
have particularly severe adverse e¡ects on their social and perso-
nal life (Shah et al, 1993). Thus far, the molecular mechanisms un-
derlying the pathogenesis of vitiligo are unclear (Taeb, 2000). A
number of therapeutic modalities are available but there is not yet
an e¡ective and optimal method to treat all patients with vitiligo.
Topical and systemic psoralen-based photochemotherapies, such
as psoralen^ultraviolet A (PUVA) therapy, are at present the most
e¡ective treatments available to induce repigmentation of vitiligo
lesions (Shah et al, 1993).
Little is known, however, about the mechanism by which
PUVA or psoralens induce repigmentation of vitiliginous skin.
Gradual repigmentation throughout the entire area of vitiligo is
generally not seen in established vitiligo treated with PUVA, but
in patients that are successfully treated with PUVA, islands of re-
pigmentation appear that coalesce to normalize pigmentation.
Those patterns of repigmentation are usually centered around
hair follicles, which suggests that functional melanocytes migrate
out from those follicles (Norris et al, 1994). Staricco (1962) was the
¢rst to demonstrate a reservoir of DOPA-negative melanocytes in
the outer root sheath (ORS) of hair follicles that could be acti-
vated by ultraviolet (UV) radiation. Ortonne et al (1980) also ex-
amined areas of PUVA-induced repigmentation in vitiligo and
found proliferating DOPA-positive melanocytes in the ORS of
hair follicles. Cui et al (1991) veri¢ed those ¢ndings by contrasting
inactive ORS melanocytes in normal skin with proliferating and
migrating cells in PUVA-treated skin. Despite this, an e¡ective
approach to activate precursor melanocytes in the ORS is not
yet available, but is a promising approach to treat vitiligo.To date,
no successful methods exist to isolate, characterize, or modulate
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the function of DOPA-negative ORS melanocytes (Norris et al,
1994).
Sviderskaya et al (1995) successfully generated an immortal
line of melanoblasts, termed melb-a cells. Melanoblasts are
de¢ned as unpigmented but committed precursors of melano-
cytes (Sviderskaya et al, 2001), and in fact the characteristic
phenotype of melanoblasts includes a lack of expression of tyro-
sinase and no DOPA staining or melanin production, even
though they express other melanocyte markers such as Tyrp1 and
Dct. Thus, those cells provide an ideal model to study processes
regulating the transition from unpigmented melanoblasts to
pigmented melanocytes, and to characterize the mechanisms
involved.
Recent studies have shown that psoralens can directly stimulate
melanogenesis by increasing the activity and synthesis of tyrosi-
nase in the absence of UV (Marwan et al, 1990; Mengeaud and
Ortonne, 1994; Lei et al, 2002). In addition, evidence has accumu-
lated that the microphthalmia-associated transcription factor
(Mitf) plays a pivotal role in regulating melanocyte di¡erentia-
tion and ultimately in controlling melanogenesis (Busca and Bal-
lotti, 2000; Tachibana, 2000). Furthermore, proteasome-mediated
proteolysis of tyrosinase has recently been shown to be integrally
involved in regulating the pigmented phenotype of melanocytes
(Halaban et al, 1997; Ando et al, 1999); however, whether psoralens
such as 8-methoxypsoralen (8MOP) can directly stimulate mela-
noblasts to produce tyrosinase and melanin is not known at this
time, nor is whether Mitf, the protein kinase A (PKA) and/or
protein kinase C (PKC) signal pathways, and/or proteasome-
mediated degradation of tyrosinase might play roles in such
responses.
The overall purpose of this study was to characterize whether
melanoblasts could be elicited by 8MOP to produce tyrosinase
and melanin, and if so, what molecular mechanism(s) might be
involved. In addition to characterizing tyrosinase activity, mela-
nin content, and the proliferation of melanoblasts treated with
8MOP, we have also examined the e¡ect of 8MOP on the expres-
sion of tyrosinase, TRP1/Tyrp1, and TRP2/Dct at the transcrip-
tional and post-transcriptional levels, and on the degradation of
tyrosinase by proteasomes.
MATERIALS AND METHODS
Materials 8MOP, 1-oleoyl-2-acetylglycerol (OAG), N-2-[p-Bromo-
cinnamylamino]ethyl-5-isoquinolinesulfonamide hydrochloride (H89),
forskolin, and phorbol 12,13-dibutyrate (PDBu) were purchased from
Sigma (St. Louis, MO). 2-[1-(3-(Amidinothio)propyl)-1H-indol-3-yl]-
3-1-methylindol-3-ylmaleimide methanesulfonate (Ro31^8220) was
purchased from BioMol (Plymouth Meeting, PA). Lactacystin was
from Calbiochem (La Jolla, CA). The C5 monoclonal antibody against
Mitf was from Lab Vision (Fremont, CA). The aPEP7, aPEP1,
and aPEP8 polyclonal antibodies were raised against the carboxyl termini
of mouse tyrosinase, Tyrp1, and Dct proteins, respectively (JimeŁ nez et al,
1991; Tsukamoto et al, 1992). Peroxidase-conjugated antimouse and
antirabbit antibodies were from Amersham Pharmacia Biotech
(Piscataway, NJ).
Cell culture and treatment Melb-a melanoblasts were a kind gift of
Dr. Dorothy C. Bennett (St. George’s Hospital, London, U.K.). They were
originally derived from C57BL/6 J (black, a/a) mice (Sviderskaya et al, 1995)
and were grown in a humidi¢ed atmosphere with 10% CO2 at 371C.They
were routinely passaged in complete RPMI 1640 medium supplemented
with 50 nM PDBu, 1 ng basic ¢broblast growth factor (bFGF) per ml,
5% fetal bovine serum, and 2 mM L-glutamine, without feeder cells.
Cells were harvested by brief treatment with trypsin/ethylenediamine
tetraacetic acid (EDTA) (Gibco, Grand Island, NY) and were sedimented
and resuspended in complete RPMI 1640 medium. Viable cells,
determined by trypan blue exclusion, were counted in a hemocytometer,
resuspended in the appropriate volume of complete RPMI 1640 medium,
and seeded at E2104 cells per cm2 in 10 cm cell culture dishes. Stock
solutions of 8MOP (100 mM), H89 (10 mM), and Ro31^8220 (10 mM)
were prepared weekly in dimethylsulfoxide (DMSO) and were protected
from light. Stock solutions were diluted to the appropriate concentrations
immediately before use. Melanoblasts were cultured in the presence of the
phorbol ester, PDBu, instead of 12-O-tetradecanoyl-phorbol-13-acetate
(TPA) because the water-soluble PDBu can be removed by repeated
washing. Thus, the in£uence of residual TPA released from melanoblasts
could be avoided (Valyi-Nagy et al, 1990).
To examine the e¡ects of various factors on melanoblasts, PDBu
and bFGF were replaced by 100 mM 8MOP, 10 mM forskolin, or
10 mM OAG in the presence of 10% fetal bovine serum. 8MOP
was used at 100 mM in this study as a previous study by our group
showed that this was the maximally e¡ective concentration (Lei et al,
2002); that optimal dose was also con¢rmed in this study. Ten mM
forskolin and 10 mM OAG are standard concentrations used in the
literature to treat melanocytes (Hirobe, 1994; Bilodeau et al, 2001).
Equivalent volumes of diluent (DMSO) were added to untreated control
dishes. After allowing 1 d for cell attachment, the medium was
changed and compounds were added in fresh complete RPMI 1640
medium. Culture media were replaced every 2 d for 6 d (a total of three
treatments).
To examine e¡ects of PKA or PKC inhibitors, melanoblasts were
pretreated with H89 or Ro31^8220 for 20 min at ¢nal concentrations of 1,
5, or 10 mM, and then were treated for 6 d in the presence or absence of 100
mM 8MOP with H89 or Ro31^8220 at those concentrations, according to
previously published protocols (Schultz et al, 1997; Rahn Landstrom et al,
2000).
For evaluating tyrosinase degradation, cells were treated with
proteasome inhibitors and/or 8MOP for 1 d or 3 d, as detailed below.
Radiometric assay for tyrosinase activity Tyrosinase activity was
measured as previously described (Virador et al, 1999). Brie£y, cells were
harvested with trypsin/EDTA, 2 ml of fresh complete RPMI 1640
medium was added to inactivate the trypsin, and 100 ml aliquots were
seeded into £at-bottom 96-well plates for the MTT assay, as described
below. The remainder of the cell suspensions were centrifuged for 5 min
at 1500 g, washed with Dulbecco’s phosphate-bu¡ered saline (PBS)
(without Ca and Mg), and then solubilized in 240 ml extraction
bu¡er [1% Nonidet P-40, 0.01% sodium dodecyl sulfate (SDS), 0.1 M
Tris^HCl, pH 7.2, and protease inhibitor cocktail (Roche, Indianapolis,
IN)]. Extracts were solubilized at 41C for 1 h and 30 ml of each extract
were added to wells of 96-well microtiter plates in quadruplicate. Ten
microliters L-[14C] tyrosine were added to each well along with 10 ml 0.25
mM L-Dopa cofactor in 1M sodium phosphate bu¡er, pH 7.2, containing
0.01% albumin. Reactions were incubated for 1^2 h at 371C, after
which 100 ml 0.1 M HCl with excess unlabeled L-tyrosine was added to
each well. The contents of each well were removed with a multichannel
pipettor to a dot-blot apparatus (Bio-Rad, Hercules, CA) and acid-
insoluble radioactive melanin and melanin precursors were bound to
ZetaProbe blotting membranes (Bio-Rad) for 15 min at 231C. The
membranes were then dried under vacuum and washed three times with
250 ml 0.1 M HCl; they were removed from the apparatus and washed
three times for 20 min each with 100 ml 0.1 M HCl. Membranes were
then air-dried and exposed to a Storm phosphor screen; quantitation of
radioactive melanin production on the blots was performed using a Storm
860 PhosphorImager and ImageQuant software (Molecular Dynamics,
Rockville, MD).
Measurement of cell proliferation and melanin content An MTT
assay kit (Roche) was used to determine cell proliferation, as detailed
previously (Virador et al, 1999). After treatment, 100 ml aliquots
of harvested cells were plated in £at-bottom 96-well microtiter plates,
as described above. Cells were allowed to attach and grow over-
night at 371C before performing the MTT assay, according to the
manufacturer’s instructions. The formazan precipitates were quantitated
by absorbance at 562 nm in a SpectraMax 250 ELISA
reader (Molecular Devices, Sunnyvale, CA), with a reference wavelength
of 690 nm.
Melanin content was determined using a published protocol (Curto et al,
1999) with minor modi¢cations. The cells were lyzed with 200 ml 1 N
NaOH and pipetted repeatedly to homogenize the extracts. For analysis,
the extracts were then transferred into 96-well plates in duplicate.
Relative melanin contents were determined by absorbance at 405 nm
using a SpectraMax 250 ELISA reader.
Western blot analysis Cells were treated as indicated in the ¢gure
legends. At the end of each treatment period, cells were washed in PBS
and were lyzed in extraction bu¡er containing 1% Nonidet P-40, 0.01%
SDS, and the protease inhibitor cocktail. Protein contents were
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determined with a BCA assay kit (Pierce, Rockford, IL) and equal amounts
of each protein extract (5 mg per lane) were resolved using 8% SDS
polyacrylamide gel electrophoresis (SDS-PAGE). Following transblotting
onto Immobilon-P membranes (Millipore, Bedford, MA) and blocking in
5% nonfat milk in saline bu¡er, the membranes were incubated with
aPEP7, aPEP1, or aPEP8 (each at a 1:2000 dilution) or with the C5
monoclonal antibody (at a 1:500 dilution). The membranes were then
incubated with horseradish-peroxidase-conjugated antirabbit or mouse IgG
at a dilution of 1:2000. Immunoreactive bands were detected by enhanced
chemiluminescence using an ECL kit (Amersham, Piscataway, NJ) and
were quantitated using ScionImage software (Scion, Frederick, MD).
RNA isolation and reverse transcriptase polymerase chain reaction
(RT-PCR) To assess the e¡ects of 8MOP or forskolin on mRNA
expression, semiquantitative RT-PCR was performed. Total RNA
was extracted from cultured cells using an RNeasy total RNA
isolation kit (QIAGEN, Valencia, CA) following the supplied protocol.
Five hundred nanograms of each RNA sample was treated with
RNase-free DNase I (Gibco) containing 1 U RNase inhibitor (Gibco) to
remove contaminating DNA.The DNase-treated RNA samples were then
reverse transcribed at 501C for 32 min using the SuperScript One-Step
RT-PCR kit (Gibco). The cDNAwas ampli¢ed in a Perkin-Elmer Cetus
thermal cycler using Taq DNA polymerase. PCR was run for Mitf (26
cycles at 961C for 0.5 min, 661C for 1.5 min), tyrosinase (30 cycles at 941C
for 0.5 min, 551C for 1 min, 721C for 1 min), and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) (26 cycles at 941C for 0.5min,
641C for 1.5min) with a ¢nal extension at 721C for 5 min. PCR products
were separated on a 1.8% agarose gel containing ethidium bromide
(500 ng per ml) and sizes were estimated with 100 bp DNA ladder
(InVitrogen, Carlsbad, CA). Oligonucleotide primers used for PCR
were based on published mRNA sequences and were as follows:
mouse tyrosinase (Chakraborty et al, 1999) (forward) 50 -TTC AAA
GGG GTG GAT GAC-30 and (reverse) 50 -GAC ACA TAG TAA TGC
ATC-30; mouse Mitf (Powers and Davidson, 1996) (forward) AGT CAC
TAC CAG GTG CAG AC-30 and (reverse) 50 -CTT GCT TCA GAC TCT
GTGGG-30; and mouse GAPDH (Ogawa et al, 2000). With these primer
sets, the PCR products for tyrosinase, Mitf, and GAPDH were 341 bp,
569 bp, and 729 bp, respectively. Blots were quantitated using ScionImage
software.
RESULTS
8MOP and/or forskolin stimulates melanoblast pigmen-
tation In this study, we observed that immortalized melb-a
melanoblasts could be grown and subcultured in RPMI 1640
medium containing PDBu and bFGF, but in the absence of
feeder cells. The addition of PDBu and bFGF sustained the
proliferation and phenotype of these murine melanoblasts, and
inhibited their pigmentation as previously reported (Sviderskaya
et al, 1995). Once they were deprived of those factors, they rarely
but occasionally began to spontaneously synthesize melanin. The
characteristic appearance of melanoblasts is mainly bipolar,
tripolar, polypolar, or dendritic and with small dark nuclei
(Bennett et al, 1989; Hirobe, 1992), as seen by phase optics in
Fig 1. When melanoblasts were exposed to 8MOP for several
days or longer, more of them became pigmented and dendritic
compared with untreated controls (the pigmentation is easiest to
see in the bright ¢eld panels). Forskolin, a cAMP-elevating agent,
had a similar stimulating e¡ect on melanoblasts and, when used
in conjunction with 8MOP, stimulated their pigmentation more
obviously, whereas OAG, a PKC activator, had no such e¡ect.
These results show that 8MOP can directly stimulate
melanoblast pigmentation in vitro.
8MOP and/or forskolin stimulates the pigmentation but not
the proliferation of melanoblasts We then determined the
tyrosinase activity, melanin content, and proliferation rates of
melanoblasts exposed to 8MOP, forskolin, and/or OAG. When
melanoblasts were treated with 8MOP for 2, 3, or 6 d,
signi¢cant increases in tyrosinase activity and in melanin
content occurred in a time-dependent manner (data not shown).
Maximal stimulation of melanogenesis was obtained following
treatment with 100 mM 8MOP for 6 d (Fig 2). Compared with
controls, tyrosinase activity was increased 7-fold and melanin
content was increased 3-fold after 6 d of treatment with
8MOP. Forskolin stimulated tyrosinase activity and melanin
content 12-fold and 3-fold, respectively, and both parameters
of melanogenesis were signi¢cantly higher when exposed
concomitantly to forskolin and 8MOP for 6 d. In contrast,
but consistent with the results shown in Fig 1, OAG did
not stimulate tyrosinase activity or melanin content of
melanoblasts. In general, none of these agents signi¢cantly
a¡ected rates of melanoblast growth except forskolin, which
stimulated it slightly. Taken together, these results suggest
that melanoblast pigmentation is stimulated by 8MOP
through activation of the PKA pathway rather than the PKC
pathway.
Tyrosinase expression is increased in melanoblasts exposed
to 8MOP and/or forskolin Melanin synthesis takes place in
melanocytes after their di¡erentiation from melanoblasts
(Bertolotto et al, 1998). Three melanocyte-speci¢c enzymes,
tyrosinase (Hearing, 1987), tyrosinase-related protein 1 (Tyrp1)
(JimeŁ nez-Cervantes et al, 1994; Kobayashi et al, 1994), and
tyrosinase-related protein 2 (Dct) (Jackson et al, 1992), are
involved in catalytic processes that convert tyrosine to melanin.
To further characterize those enzymes during 8MOP-induced
pigmentation, we examined their expression using Western blot
analysis (Fig 3). Tyrosinase in untreated melanoblasts was just
Figure1. 8MOP and/or forskolin stimulates melanoblast pigmenta-
tion. Melb-a melanoblasts were cultured for 6 d in RPMI 1640 medium
(without PDBu or bFGF) containing 8MOP, forskolin, and/or OAG as
noted. Identical ¢elds are shown by phase-contrast (top panels) and by
bright-¢eld optics (bottom panels); bar=100 mm (5.8 mm). Photographic
parameters, such as light levels, were matched for comparability. Control,
DMSO vehicle only; 8MOP,100 mM 8MOP; FOR,10 mM forskolin; OAG,
10 mM OAG.
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barely detectable, but treatment with 8MOP induced signi¢cant
(6- to 9-fold) increases in tyrosinase within 6 d, which was
consistent with the enzyme assays reported above. Furthermore,
treatment with forskolin alone or in the presence of
8MOP dramatically enhanced (4 25-fold) levels of tyrosinase,
but again, OAG had no e¡ect in the presence or absence of
8MOP. In contrast, the two other melanogenic enzymes, Tyrp1
and Dct, were readily detectable in the untreated controls, and
8MOP (or forskolin or OAG) had little or no e¡ect on those
levels. Therefore, these results demonstrate that the de novo
synthesis of tyrosinase accounts for the 8MOP stimulation
of melanoblast pigmentation, and further suggest that the
PKA pathway (and not the PKC pathway) is crucial for that
process.
Inhibitors of PKA abrogate the stimulation of melanoblast
pigmentation elicited by 8MOP To further characterize the
signaling mechanisms involved in the stimulation of
melanoblast pigmentation by 8MOP, we examined the e¡ects of
inhibiting the PKA or PKC pathways using potent inhibitors of
PKA (H89) or PKC (Ro31^8220) (Carsberg et al, 1994; Yoshida
et al, 2000). As expected from the results presented above, 100
mM 8MOP signi¢cantly stimulated the morphologic changes
(Fig 4a), and tyrosinase activity and melanin content (Fig 4b),
but had no e¡ect on proliferation (Fig 4b). Treatment with
H89, however, suppressed the stimulatory e¡ects of 8MOP on
the morphology, tyrosinase activity, and melanin content of
melb-a melanoblasts in a dose-dependent manner (Fig 4a, b).
In contrast, Ro31^8220 had no signi¢cant e¡ect on the
stimulation of melanoblasts by 8MOP. Both H89 and
Ro31^8220 were toxic at the higher concentrations tested,
but at concentrations that were not toxic (1 or 5 mM H89 and 1
mM Ro31^8220), Western blot analysis showed that H89
signi¢cantly suppressed the stimulation of tyrosinase expression
by 8MOP, whereas Ro31^8220 had no e¡ect (Fig 4c). Thus,
these results support the conclusion that 8MOP stimulates the
pigmentation of melanoblasts via the PKA, but not the PKC,
pathway.
8MOP and/or forskolin rapidly stimulate Mitf mRNA and
protein expression compared with tyrosinase Earlier
studies showed that the Mitf locus encodes a helix^loop^helix
(HLH) transcription factor that plays a pivotal role in
determining melanocyte survival, development, and di¡erenti-
ation (Hodgkinson et al, 1993; Busca and Ballotti, 2000;
Tachibana, 2000). Thus, we examined whether Mitf expression is
involved in the stimulation of melanoblast pigmentation by
8MOP and/or forskolin. mRNA and protein levels for Mitf and
tyrosinase were assessed using semiquantitative RT-PCR and
Western blot analysis, respectively. Incubation with 8MOP and/
or forskolin elicited increases in Mitf mRNA (Fig 5) within 3
h, which were maximized at 6 h. Levels of Mitf protein
were similarly increased in response to 8MOP and/or forskolin
(Fig 6) within 3^6 h. Mitf protein levels had returned
to baseline levels by 6 d, as had Mitf mRNA levels. In a
similar but delayed fashion, 8MOP and/or forskolin had a
detectable e¡ect on tyrosinase expression at the mRNA and
Figure 2. 8MOP and/or forskolin stimulates the pigmentation but
not the growth of melanoblasts. Tyrosinase activity, melanin content,
and cell proliferation of melanoblasts treated with DMSO (control),
100 mM 8MOP, 10 mM forskolin (FOR), and/or 10 mM OAG for 6 d are
shown. Data are reported as n-fold compared with the controls and repre-
sent the means (7SEM) of three separate experiments. Signi¢cance of dif-
ferences is assessed by the two-tailed and paired Student’s test. npo 0.05
from control, nnpo 0.01 from control, nnnpo 0.001 from 8MOP or FOR.
Figure 3. Tyrosinase, but not Tyrp1 or Dct, expression is stimulated
by 8MOP and/or forskolin. Cells were treated for 6 d with 8MOP, for-
skolin, and/or OAG as noted. Ten micrograms total protein from extracts
of untreated cells (control) or from cells treated with 100 mM 8MOP,10 mM
forskolin (FOR), and/or 10 mM OAG were separated on 8% SDS-PAGE
gels and transferred to PVDF membranes. Speci¢c detection of tyrosinase,
Tyrp1, and Dct was performed with the antibodies aPEP7, aPEP1, and
aPEP8, respectively. Molecular masses, indicated on the left, are expressed
in kDa. The blots shown are representative of three di¡erent experiments
that had similar results. Arrows point to the bands of interest, and the num-
ber at the bottom of each gel represents densitometric scans of the bands
reported as n-fold compared with the controls.
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protein levels, but only at 1 d and thereafter. Thus, our
observations show that treatment of melanoblasts with 8MOP
and/or forskolin leads to a rapid, transient increase in Mitf
mRNA and protein. Similarly, 8MOP and/or forskolin elicited
dramatic increases in tyrosinase mRNA and protein that were
detectable after 1 d of treatment.
Inhibiting proteasome activity mimics the e¡ect of 8MOP
on tyrosinase Degradation of tyrosinase by proteasomes has
been recently reported to regulate the level of melanin
production at the post-transcriptional level (Halaban et al, 1997;
Ando et al, 1999; Toyofuku et al, 2001). To assess whether the
inhibition of tyrosinase degradation by proteasomes might
contribute to the increased pigmentation of melanoblasts
elicited by 8MOP, we used Western blot analysis to examine
the e¡ects of the known proteasome inhibitor, lactacystin,
on tyrosinase degradation in the presence or absence of
8MOP. Treatment of melanoblasts with lactacystin alone for 1 d
elicited an increase in tyrosinase protein levels compared with the
control (Fig 7). Treatment with lactacystin and 8MOP led to
even greater levels of tyrosinase, which was more than
the increase elicited by 8MOP alone. More dramatic e¡ects
were seen at 3 d, and it should be noted that the melb-a
melanoblasts tolerated these reagents quite well, remaining
Figure 4. Inhibitors of PKA abrogate the stimulation of melanoblast pigmentation by 8MOP. (a) Phenotypic changes of melb-a melanoblasts
were observed by phase-contrast (left column) and by bright-¢eld optics (right column) after treatment for 6 d with DMSO only (control) or with 8MOP,
with or without H89 or Ro31^8220; bar=100 mm (6.6 mm). (b) Tyrosinase activity, melanin content, and cell proliferation of melanoblasts treated with
various concentrations of H89 or Ro31^8220 in the absence (open bars) or presence (closed bars) of 100 mM 8MOP for 6 d. Data are reported as n-fold
compared with the control and represent the means (7SEM) of three separate experiments. (c) Western blot analysis of tyrosinase protein in melanoblasts
treated for 6 d with agents as noted. Ten micrograms total protein from extracts of cells treated with DMSO only (control) or from cells treated with
100 mM 8MOP (8MOP) in the presence or absence of 5 mMH89 or 1 mMRo31^8220 (Ro) were separated on 8% SDS-PAGE gels and transferred to PVDF
membranes. Speci¢c detection of tyrosinase was performed with the antibody aPEP7. The arrow points to the band of interest, and the number at
the bottom of each gel represents densitometric scans of the bands reported as n-fold compared with the control. The results are representative of two
experiments.
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viable and proliferative throughout the time course of these
experiments.
DISCUSSION
These data clearly demonstrate that 8MOP can stimulate
melanoblast pigmentation by increasing the expression of
tyrosinase, which is accompanied by upregulation of tyrosinase
catalytic function and melanin production. Melb-a melanoblasts
are immortalized cells derived from neonatal black mouse
skin, which lack a functional tyrosinase catalytic activity. We
show in this study that when unpigmented melanoblasts are
exposed to 8MOP, many of them become pigmented, but with
no e¡ect on rates of cell growth. Tyrosinase catalytic function
increased about 7-fold within 6 d and melanin content increased
about 3-fold compared with untreated controls. Interestingly,
these cells express other components of the melanogenic
machinery, such as Tyrp1 and Dct, and levels of those proteins
are relatively una¡ected by treatment with 8MOP. Because
tyrosinase is the rate-limiting enzyme in melanin production, its
function is really the critical factor regulating pigmentation.
Melanocyte stimulating hormone and UV light are well-known
stimulants of melanocyte function, and interestingly, both
of them also have their primary e¡ects on expression of
tyrosinase, whereas Tyrp1 and Dct are relatively una¡ected
(JimeŁ nez et al, 1988; Abdel-Malek et al, 1995; Mengeaud and
Ortonne, 1996).
The PKA and PKC signal pathways have been shown to
play important roles in regulating melanogenesis and the
proliferation of melanocytes in vitro (Hirobe, 1992; Mengeaud
and Ortonne, 1994). Therefore, we addressed the question of
whether the PKA and/or the PKC pathways were involved in
regulating the stimulation of melanoblast pigmentation by
8MOP. In this study, we found that tyrosinase activity and mela-
nin production of melanoblasts exposed concomitantly to forsko-
lin (a cAMP-elevating agent) and 8MOP was higher than in cells
treated with 8MOP alone or with forskolin alone. In contrast,
OAG (an activator of the PKC pathway) did not stimulate the
pigmentation of melanoblasts, suggesting that the PKC pathway
is not critically important in that response. Similar results were
obtained from Western blot analysis; 8MOP signi¢cantly in-
creased tyrosinase protein levels in melanoblasts following expo-
sure to 8MOP after 1 d. This striking stimulation by 8MOP was
further enhanced by forskolin, but not by OAG. Inhibitors of the
PKA or PKC pathway substantiated those e¡ects. Collectively,
our results show that the PKA-dependent signal pathway is in-
volved in the stimulation of melanoblast pigmentation by
8MOP, and that the PKC signal pathway is not involved in this
process.
In recent years, there has been increasing evidence that Mitf
plays a pivotal role as a master gene that regulates melanocyte
development, survival, and di¡erentiation (Busca and Ballotti,
2000; Tachibana, 2000). Mitf is a basic HLH transcription factor
containing a leucine-zipper domain. The basic region is responsi-
ble for the DNA binding, whereas the HLH motif and the
Figure 5. Mitf mRNA expression is rapidly increased by 8MOP and/or forskolin whereas induction of tyrosinase mRNA expression is
slower, as assessed by semiquantitative RT-PCR. Speci¢c primers, as described in Materials and Methods, were used to amplify cDNA obtained from
melanoblasts following treatment with DMSO solvent only, 100 mM 8MOP, and/or 10 mM forskolin (FOR) for 3 h, 6 h, 1 d, 3 d, or 6 d, as noted. Ampli-
¢cation products of tyrosinase (341 bp), Mitf (569 bp), and GAPDH (729 bp) were separated on 1.8% agarose gels; a 100 bp DNA ladder was used as
markers. Results are representative of three independent experiments that had similar results. Bands of interest are identi¢ed by arrows and the numbers at
the bottom of the blots represent densitometric scans of the bands calculated as n-fold against the relevant control.
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leucine-zipper domain are involved in protein^protein interac-
tions. Studies on the cell-speci¢c expression of tyrosinase have
shown that the M-box in the upstream promoter region of the
tyrosinase gene is required for its e⁄cient expression in melano-
cytes (Busca and Ballotti, 2000;Tachibana, 2000). This motif con-
tains a canonical CANNTG motif that is recognized and bound
by Mitf. To gain more insight into what roles might be played by
Mitf in the melanoblast response to 8MOP, we usedWestern blot
analysis and semiquantitative RT-PCR to assess the protein and
mRNA expression levels of Mitf in melanoblasts treated with
8MOP for varying times. Treatment with 8MOP rapidly in-
creased Mitf mRNA and protein levels within 3^6 h. In contrast,
tyrosinase mRNA and protein had delayed responses to 8MOP,
and took 1 d or longer to show increased levels. A reasonable in-
terpretation of these results is that 8MOP increases Mitf expres-
sion, which in turn activates tyrosinase gene expression, and this
occurs via activation of the PKA signaling pathway. The involve-
ment of proteasomes in regulating tyrosinase levels has been re-
cently shown (Halaban et al, 1997; Ando et al, 1999; Toyofuku,
2001) and our data further supports that. Proteasomes have also
been shown to be important to the regulation of Mitf function
(Busca and Ballotti, 2000;Wu et al, 2000; Xu et al, 2000), and the
e¡ects noted in this study may well be regulated at the level of
e¡ects on Mitf. As is shown in this study, even untreated melano-
blasts have ample levels of Mitf mRNA but levels of Mitf pro-
tein are negligible in those cells.We hypothesize that the increase
in Mitf protein (which would lead to increased tyrosinase expres-
sion) that is elicited by 8MOP may well depend on its e¡ects on
proteasome function, and future study will naturally be directed
toward further elucidating that possibility. The sum of these re-
sults suggests that proteasomes may be intimately involved in
Figure 7. Inhibiting proteasome activity mimics the e¡ect of
8MOP on tyrosinase protein. Melanoblasts were treated for 1 d or 3 d
with agents as noted. Ten micrograms total protein from extracts of cells
treated with DMSO only (control) or from cells treated with 100 mM
8MOP (8MOP) and/or 30 mM lactacystin (LC) were separated on 8%
SDS-PAGE gels and transferred to PVDF membranes. Tyrosinase protein
was detected with the aPEP7 antibody, as detailed inMaterials and Methods.
Molecular masses, indicated on the left, are expressed in kDa. The blot
shown is representative of two di¡erent experiments. The numbers at the
bottom of each gel represent densitometric scans of the bands calculated as
n-fold compared with the relevant control.
Figure 6. The kinetics of Mitf and tyrosinase protein expression are similar to mRNA expression following treatment with 8MOP and/or
forskolin. Melb-a melanoblasts were harvested at 3 h, 6 h, 1 d, 3 d, or 6 d following treatment with solvent only (control), 100 mM 8MOP, and/or 10 mM
forskolin (FOR). Ten micrograms of total protein were electrophoresed in 8% SDS-PAGE gels and transferred to PVDF membranes. Speci¢c detection of
Mitf and tyrosinase was then performed using the C5 and aPEP7 antibodies, respectively, as detailed inMaterials and Methods. The C5 monoclonal antibody
recognizes two isoforms of the Mitf protein in melb-a cell lysates, the 52 kDa and the 56 kDa isoforms, which represent the inactive (unphosphorylated)
and the active (phosphorylated) isoforms, respectively (noted with arrows). The doublet band seen at 69^70 kDa probably represents a nonspeci¢c reactivity.
The aPEP7 antibody also recognizes two forms of tyrosinase, the lower molecular weight form (65 kDa) being the de novo synthesized protein and the
higher molecular weight form (68 kDa) representing the glycosylated and processed forms (noted with arrows). Molecular masses, indicated on the left, are
expressed in kDa. The blots shown are representative of three di¡erent experiments with comparable results. The numbers at the bottom of each gel repre-
sent densitometric scans of the bands of interest calculated as n-fold compared with the relevant control.
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regulating the pigmentation of melanoblasts in response to
8MOP at several levels.
Previous studies have demonstrated that there are speci¢c bind-
ing sites for psoralens (psoralen receptors) located at the mamma-
lian cell membrane (Laskin et al, 1986) and that psoralens can
elevate intracellular cAMP levels (Mengeaud and Ortonne,
1994). It was therefore suspected that 8MOP might modulate
Mitf expression through binding to a psoralen receptor and acti-
vating the PKA signal pathway to elicit melanoblast pigmenta-
tion in vitro. These results therefore support a potential
mechanism whereby 8MOP activates epidermal melanoblasts,
which may be involved in the response of vitiligo skin to PUVA
therapy.
In conclusion, this study demonstrates that 8MOP can stimu-
late melanoblast pigmentation by increasing the expression of
Mitf and by subsequently increasing the stability and enzymatic
function of tyrosinase. The PKA signal pathway appears to be in-
volved in the stimulation of melanoblast pigmentation by 8MOP,
whereas the PKC signal pathway seems to be relatively unimpor-
tant to this process. New advances in understanding the molecu-
lar mechanisms of repigmentation induced by psoralens should
be useful in the future to develop new treatments or drugs for
vitiligo. This should lead to an e¡ective approach for treating vi-
tiligo, via activation of precursor melanocytes in the ORS of hair
follicles.
We would like to thank Dr. Yuji Yamaguchi for quantitating the gel bands in this
study.
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